ICU Medical, Inc.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US44930G1076
USD
126.96
1.11 (0.88%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Globus Medical, Inc.
Sotera Health Co.
ICU Medical, Inc.
CONMED Corp.
Merit Medical Systems, Inc.
Glaukos Corp.
Sanmina Corp.
Neogen Corp.
Axonics, Inc.
Integra LifeSciences Holdings Corp.
Inari Medical, Inc.

Why is ICU Medical, Inc. ?

1
Company's ability to service its debt is strong with a healthy EBIT to Interest (avg) ratio of 16.14
2
Low Debt Company with Strong Long Term Fundamental Strength
3
Positive results in Dec 25
  • NET PROFIT(HY) Higher at USD 14.46 MM
  • ROCE(HY) Highest at 0.04%
  • INTEREST COVERAGE RATIO(Q) Highest at 320.39
4
With ROCE of 3.84%, it has a risky valuation with a 1.25 Enterprise value to Capital Employed
  • The stock is trading at a discount compared to its peers' average historical valuations
  • Over the past year, while the stock has generated a return of -10.23%, its profits have risen by 142.4% ; the PEG ratio of the company is 1.2
5
High Institutional Holdings at 100%
  • These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
6
Below par performance in long term as well as near term
  • Along with generating -10.23% returns in the last 1 year, the stock has also underperformed S&P 500 in the last 3 years, 1 year and 3 months
stock-recommendationReal-Time Research Report

Verdict Report

How much should you hold?

  1. Overall Portfolio exposure to ICU Medical, Inc. should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is ICU Medical, Inc. for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
ICU Medical, Inc.
-11.5%
0.34
40.47%
S&P 500
18.81%
1.04
19.28%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
11.91%
EBIT Growth (5y)
-3.76%
EBIT to Interest (avg)
16.14
Debt to EBITDA (avg)
3.57
Net Debt to Equity (avg)
0.63
Sales to Capital Employed (avg)
0.64
Tax Ratio
100.00%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
3.70%
ROE (avg)
2.36%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
174
Industry P/E
Price to Book Value
1.37
EV to EBIT
32.45
EV to EBITDA
11.99
EV to Capital Employed
1.25
EV to Sales
1.67
PEG Ratio
1.22
Dividend Yield
NA
ROCE (Latest)
3.84%
ROE (Latest)
0.79%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bearish
Dow Theory
No Trend
Mildly Bearish
OBV
No Trend
Mildly Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

16What is working for the Company
NET PROFIT(HY)

Higher at USD 14.46 MM

ROCE(HY)

Highest at 0.04%

INTEREST COVERAGE RATIO(Q)

Highest at 320.39

RAW MATERIAL COST(Y)

Fallen by -4.81% (YoY

DEBT-EQUITY RATIO (HY)

Lowest at 48.98 %

-4What is not working for the Company
PRE-TAX PROFIT(Q)

Lowest at USD 4.55 MM

Here's what is working for ICU Medical, Inc.

Net Profit
At USD 14.46 MM has Grown at 121.21%
Year on Year (YoY)
MOJO Watch
Near term Net Profit trend is very positive

Net Profit (USD MM)

Interest Coverage Ratio
Highest at 320.39
in the last five periods
MOJO Watch
The company's ability to manage interest payments is improving

Operating Profit to Interest

Net Profit
Higher at USD 14.46 MM
than preceding 12 month period ended Dec 2025
MOJO Watch
In the half year the company has already crossed Net Profit of the previous twelve months

Net Profit (USD MM)

Debt-Equity Ratio
Lowest at 48.98 %
in the last five Semi-Annual periods
MOJO Watch
The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio

Raw Material Cost
Fallen by -4.81% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Depreciation
Highest at USD 54.34 MM
in the last five periods
MOJO Watch
The expenditure on assets done by the company may have gone into operation

Depreciation (USD MM)

Here's what is not working for ICU Medical, Inc.

Pre-Tax Profit
At USD 4.55 MM has Fallen at -78.04%
over average net sales of the previous four periods of USD 20.72 MM
MOJO Watch
Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (USD MM)

Pre-Tax Profit
Lowest at USD 4.55 MM
in the last five periods
MOJO Watch
Near term Pre-Tax Profit trend is negative

Pre-Tax Profit (USD MM)